Reference Type:  Journal Article
Record Number: 1019
Author: Runtti, H., Mattila, J., Van Gils, M., Koikkalainen, J., Soininen, H. and Lötjönen, J.
Year: 2014
Title: Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort
Journal: Journal of Alzheimer's Disease
Volume: 39
Issue: 1
Pages: 49-61
Short Title: Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort
ISSN: 13872877 (ISSN)
DOI: 10.3233/JAD-130359
Keywords: Alzheimer's disease
biomarkers
data mining
decision support techniques
early diagnosis
mild cognitive impairment
apolipoprotein E
accuracy
aged
Alzheimer disease
article
brain size
cerebrospinal fluid
cognition
controlled study
decision making
disease course
Disease State Index
educational status
female
follow up
geriatric patient
human
hypothesis
longitudinal study
major clinical study
male
memory
Mini Mental State Examination
named inventories, questionnaires and rating scales
neuroimaging
neuropsychological test
nuclear magnetic resonance imaging
patient coding
priority journal
quantitative analysis
very elderly
Abstract: Several neuropsychological tests and biomarkers of Alzheimer's disease (AD) have been validated and their evolution over time has been explored. In this study, multiple heterogeneous predictors of AD were combined using a supervised learning method called Disease State Index (DSI). The behavior of DSI values over time was examined to study disease progression quantitatively in a mild cognitive impairment (MCI) cohort. The DSI method was applied to longitudinal data from 140 MCI cases that progressed to AD and 149 MCI cases that did not progress to AD during the follow-up. The data included neuropsychological tests, brain volumes from magnetic resonance imaging, cerebrospinal fluid samples, and apolipoprotein E from the Alzheimer's Disease Neuroimaging Initiative database. Linear regression of the longitudinal DSI values (including the DSI value at the point of MCI to AD conversion) was performed for each subject having at least three DSI values available (147 non-converters, 126 converters). Converters had five times higher slopes and almost three times higher intercepts than non-converters. Two subgroups were found in the group of non-converters: one group with stable DSI values over time and another group with clearly increasing DSI values suggesting possible progression to AD in the future. The regression parameters differentiated between the converters and the non-converters with classification accuracy of 76.9% for the slopes and 74.6% for the intercepts. In conclusion, this study demonstrated that quantifying longitudinal patient data using the DSI method provides valid information for follow-up of disease progression and support for decision making. Supplementary Materials. JAD130359-Suppl.pdf . © 2014-IOS Press and the authors.
Notes: Export Date: 28 May 2014
Source: Scopus
CODEN: JADIF
Language of Original Document: English
Correspondence Address: Runtti, H.; VTT Technical Research Centre of Finland, P.O. Box 1300, Fin-33101 Tampere, Finland; email: hilkka.runtti@vtt.fi
Funding Details: EC, European Commission
Funding Details: EU-Grant-224328, EC, European Commission
References: Nestor, P.J., Scheltens, P., Hodges, J.R., Advances in the early detection of Alzheimer's disease (2004) Nature Medicine, 10 (SUPPL.), pp. S34-S41; Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R.C., Ritchie, K., Broich, K., Belleville, S., Winblad, B., Mild cognitive impairment (2006) Lancet, 367, pp. 1262-1270. , International Psychogeriatric Association Expert Conference on mild cognitive impairment; Petersen, R.C., Early diagnosis of Alzheimer's disease: Is MCI too late (2009) Curr Alzheimer Res, 6, pp. 324-330; Brooks, L.G., Loewenstein, D.A., Assessing the progression of mild cognitive impairment to Alzheimer's disease: Current trends and future directions (2010) Alzheimers Res Ther, 2, p. 28; Sloane, P.D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., Sudha, S., The public health impact of Alzheimer's disease, 2000-2050: Potential implication of treatment advances (2002) Annual Review of Public Health, 23, pp. 213-231. , DOI 10.1146/annurev.publhealth.23.100901.140525; Salloway, S., Mintzer, J., Weiner, M.F., Cummings, J.L., Disease-modifying therapies in Alzheimer's disease (2008) Alzheimers Dement, 4, pp. 65-79; Galimberti, D., Scarpini, E., Disease-modifying treatments for Alzheimer's disease (2011) Ther Adv Neurol Disord, 4, pp. 203-216; Duara, R., Barker, W., Loewenstein, D., Bain, L., The basis for disease-modifying treatments for Alzheimer's disease: The sixth annual mild cognitive impairment symposium (2009) Alzheimers Dement, 5, pp. 66-74; Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E., Alzheimer's disease (2011) Lancet, 377, pp. 1019-1031; Hampel, H., B̈urger, K., Teipel, S.J., Bokde, A.L., Zetterberg, H., Blennow, K., Core candidate neurochemical and imaging biomarkers of Alzheimer's disease (2008) Alzheimers Dement, 4, pp. 38-48; Borroni, B., Premi, E., Di Luca, M., Padovani, A., Combined biomarkers for early Alzheimer disease diagnosis (2007) Current Medicinal Chemistry, 14 (11), pp. 1171-1178. , http://www.ingentaconnect.com/content/ben/cmc/2007/00000014/00000011/ art00001, DOI 10.2174/092986707780598005; Craig-Schapiro, R., Fagan, A.M., Holtzman, D.M., Biomarkers of Alzheimer's disease (2009) Neurobiol Dis, 35, pp. 128-140; Jack Jr., C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2010) Lancet Neurol, 9, pp. 119-128; Jack Jr., C.R., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., Shaw, L.M., Trojanowski, J.Q., Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers (2013) Lancet Neurol, 12, pp. 207-216; Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Phelps, C.H., Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 280-292; Albert, M.S., Dekosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., Phelps, C.H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 270-279; McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack Jr., C.R., Kawas, C.H., Klunk, W.E., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 263-269; Jack Jr., C.R., Albert, M.S., Knopman, D.S., McKhann, G.M., Sperling, R.A., Carrillo, M.C., Thies, B., Phelps, C.H., Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 257-262; Cui, Y., Liu, B., Luo, S., Zhen, X., Fan, M., Liu, T., Zhu, W., Jin, J.S., Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors (2011) PLoS One, 6, pp. e21896. , The Alzheimer's Disease Neuroimaging Initiative; Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q., Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification (2011) Neurobiol Aging, 32, pp. 2322e19-2322e27; Ewers, M., Walsh, C., Trojanowski, J.Q., Shaw, L.M., Petersen, R.C., Jack Jr., C.R., Feldman, H.H., Hampel, H., Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance (2012) Neurobiol Aging, 33, pp. 1203-1214. , North American Alzheimer's Disease Neuroimaging Initiative (ADNI); Mattila, J., Koikkalainen, J., Virkki, A., Simonsen, A., Van Gils, M., Waldemar, G., Soininen, H., L̈otj̈onen, J., A disease state fingerprint for evaluation of Alzheimer's disease (2011) J Alzheimers Dis, 27, pp. 163-176. , The Alzheimer's Disease Neuroimaging Initiative; Zhang, D., Shen, D., Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers (2012) PLoS One, 7, pp. e33182. , The Alzheimer's Disease Neuroimaging Initiative; Gray, K.R., Aljabar, P., Heckemann, R.A., Hammers, A., Rueckert, D., Random forest-based similarity measures for multi-modal classification of Alzheimer's disease (2012) Neuroimage, 65, pp. 167-175. , The Alzheimer's Disease Neuroimaging Initiative; Mattila, J., Soininen, H., Koikkalainen, J., Rueckert, D., Wolz, R., Waldemar, G., L̈otj̈onen, J., Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects (2012) J Alzheimers Dis, 32, pp. 969-979. , The Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Neuroimaging Initiative, , http://adni.loni.ucla.edu, Accessed on May 4, 2013; Weiner, M.W., Aisen, P.S., Jack Jr., C.R., Jagust, W.J., Trojanowski, J.Q., Shaw, L., Saykin, A.J., Schmidt, M., The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) Alzheimers Dement, 6, pp. 202-211. , The Alzheimer's Disease Neuroimaging Initiative; (2011) ADNI1 Procedures Manual, , http://www.adni-info.org/Scientists/Pdfs/ ADNI1ProceduresManualRevised12052011.pdf, Posted on May 12, 2011, Accessed on January 23 2012; Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., Van Der Kouwe, A., Dale, A.M., Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain (2002) Neuron, 33 (3), pp. 341-355. , DOI 10.1016/S0896-6273(02)00569-X; Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Scheltens, P., Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria (2007) Lancet Neurology, 6 (8), pp. 734-746. , DOI 10.1016/S1474-4422(07)70178-3, PII S1474442207701783; McKhann, G., Drachman, D., Folstein, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease (1984) Neurology, 34 (7), pp. 939-944; Llano, D.A., Laforet, G., Devanarayan, V., Derivation of a new ADAS-cog composite using tree-based multivariate analysis: Prediction of conversion from mild cognitive impairment to Alzheimer disease (2011) Alzheimer Dis Assoc Disord, 25, pp. 73-84. , The Alzheimer's Disease Neuroimaging Initiative; Caroli, A., Frisoni, G.B., The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort (2010) Neurobiol Aging, 31, pp. 1263-1274. , The Alzheimer's Disease Neuroimaging Initiative; Mouiha, A., Duchesne, S., Toward a dynamic biomarker model in Alzheimer's disease (2012) J Alzheimers Dis, 30, pp. 91-100. , The Alzheimer's Disease Neuroimaging Initiative; Samtani, M.N., Farnum, M., Lobanov, V., Yang, E., Raghavan, N., Dibernardo, A., Narayan, V., An improved model for disease progression in patients from the Alzheimer's Disease Neuroimaging Initiative (2012) J Clin Pharmacol, 52, pp. 629-644. , The Alzheimer's Disease Neuroimaging Initiative; Escudero, J., Ifeachor, E., Zajicek, J.P., Bioprofile analysis: A new approach for the analysis of biomedical data in Alzheimer's disease (2012) J Alzheimers Dis, 32, pp. 997-1010. , The Alzheimer's Disease Neuroimaging Initiative; Jedynak, B.M., Lang, A., Liu, B., Katz, E., Zhang, Y., Wyman, B.T., Raunig, D., Prince, J.L., Acomputational neurodegenerative disease progression score: Method and results with the Alzheimer's Disease Neuroimaging Initiative cohort (2012) Neuroimage, 63, pp. 1478-1486. , The Alzheimer's Disease Neuroimaging Initiative; Yang, E., Farnum, M., Lobanov, V., Schultz, T., Verbeeck, R., Raghavan, N., Samtani, M.N., Dibernardo, A., Quantifying the pathophysiological timeline of Alzheimer's disease (2011) J Alzheimers Dis, 26, pp. 745-753. , The Alzheimer's Disease Neuroimaging Initiative; Cui, Y., Sachdev, P.S., Lipnicki, D.M., Jin, J.S., Luo, S., Zhu, W., Kochan, N.A., Wen, W., Predicting the development of mild cognitive impairment: A newuse of pattern recognition (2012) Neuroimage, 60, pp. 894-901; Zhang, D., Wang, Y., Zhou, L., Yuan, H., Shen, D., Multimodal classification of Alzheimer's disease and mild cognitive impairment (2011) Neuroimage, 55, pp. 856-867. , The Alzheimer's Disease Neuroimaging Initiative; Koikkalainen, J., P̈ol̈onen, H., Mattila, J., Van Gils, M., Soininen, H., L̈otj̈onen, J., Improved classification of Alzheimer's disease data via removal of nuisance variability (2012) PLoS One, 7, pp. e31112. , The Alzheimer's Disease Neuroimaging Initiative
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84892715790&partnerID=40&md5=2ee03ec10781ed41ea75ef0bb1beb47f
Author Address: VTT Technical Research Centre of Finland, P.O. Box 1300, Fin-33101 Tampere, Finland
Department of Neurology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland


